Wallroth Donald E.

Former Chief Financial Officer at Molecular Insight Pharmaceuticals, Inc. · on record since Feb 16, 2010
Chief Financial Officer at Molecular Insight Pharmaceuticals, Inc. · on record since Aug 27, 2007

Insider trading activity of Wallroth Donald E.

Transactions on record: 20; since May 8, 2008

Open-market buys: 0

Open-market sells: 2; $24.6K

Companies traded: 1; last filing Feb 16, 2010

Figures computed from official regulatory filings — methodology.

Companies where Wallroth Donald E. has traded

Molecular Insight Pharmaceuticals, Inc.20 tx · $172.2K · Feb 16, 2010

Track record of Wallroth Donald E.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Wallroth Donald E.

Co-insiders of Wallroth Donald E.

Abdalian Charles H JrMolecular Insight Pharmaceuticals, Inc.
Attarian Mark AMolecular Insight Pharmaceuticals, Inc.
Babich John WMolecular Insight Pharmaceuticals, Inc.
Barlow David SMolecular Insight Pharmaceuticals, Inc.
Barrett John AMolecular Insight Pharmaceuticals, Inc.
Borys NicholasMolecular Insight Pharmaceuticals, Inc.
BRODY KENNETH DMolecular Insight Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	13,500	3.93	$53.1K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-4,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	4,000	3.93	$15.7K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	4,000	3.93	$15.7K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	8,000	3.93	$31.4K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-13,500	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-4,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-8,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	4,000	3.93	$15.7K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-4,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-4,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	4,000	3.93	$15.7K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Other	-13,500	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 26, 2009	Sell	-2,500	3.75	$9.4K	SEC
Molecular Insight Pharmaceuticals, Inc.	May 26, 2009	Sell	-4,000	3.80	$15.2K	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AwardD	90,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AwardD	30,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AwardD	60,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 22, 2008	Award	20,000	0.01	$200	SEC
Molecular Insight Pharmaceuticals, Inc.	May 8, 2008	AwardD	40,000	0.00	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	13,500	3.93	$53.1K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-4,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	4,000	3.93	$15.7K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	4,000	3.93	$15.7K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	8,000	3.93	$31.4K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-13,500	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-4,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-8,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	4,000	3.93	$15.7K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-4,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	ExerciseD	-4,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Exercise	4,000	3.93	$15.7K	SEC
Molecular Insight Pharmaceuticals, Inc.	Feb 16, 2010	Other	-13,500	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 26, 2009	Sell	-2,500	3.75	$9.4K	SEC
Molecular Insight Pharmaceuticals, Inc.	May 26, 2009	Sell	-4,000	3.80	$15.2K	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AwardD	90,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AwardD	30,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 14, 2009	AwardD	60,000	0.00	$0	SEC
Molecular Insight Pharmaceuticals, Inc.	May 22, 2008	Award	20,000	0.01	$200	SEC
Molecular Insight Pharmaceuticals, Inc.	May 8, 2008	AwardD	40,000	0.00	$0	SEC